Skip to main content
Annals of Laboratory Medicine logoLink to Annals of Laboratory Medicine
. 2019 Jan 10;39(3):340–342. doi: 10.3343/alm.2019.39.3.340

Septicemia Caused by Herbaspirillum huttiense Secondary to Pneumonia

Changseung Liu 1, Mi Jeong Kwon 1, Myungsook Kim 1, Jung-Hyun Byun 1,, Dongeun Yong 1, Kyungwon Lee 1
PMCID: PMC6340845  PMID: 30623628

Dear Editor,

Herbaspirillum species are non-fermenting gram-negative bacilli of the class Betaproteobacteria, found in the environment, including soil, groundwater, and drinking water distribution systems [1]. They are curved or sometimes helical in shape, strict aerobes, motile with polar flagella, and urease-, oxidase-, and catalase-positive [2]. These species are rarely associated with human infections but can cause bacteremia and sepsis in immunocompromised patients [3]. Human disease caused by Herbaspirillum species has been previously described in cystic fibrosis patients. Herbaspirillum has been reported to be an opportunistic pathogen in patients with cirrhosis and cancer as well as a cause of pneumonia in an immunocompetent farmer in the United States [4]. We report the first case of septicemia caused by Herbaspirillum huttiense in Korea. This study was approved by the Institutional Review Board for Human Research, Yonsei University, Severance Hospital (IRB No. 4-2018-0620) with waiver for informed consent.

A 93-year-old male was admitted to the hospital with seizures and fever. Although the patient was of advanced age, he had no remarkable past medical history except for hypertension, for which he was on medication. The patient was suspected to have encephalitis, and vancomycin and ceftriaxone were administered to him immediately. Initial blood, sputum, and cerebrospinal fluid bacterial cultures showed no growth of pathogens. After a few days, dyspnea, O2 desaturation (85%), tachycardia, and profound hypotension were observed, and radiological examinations showed pneumonia. Staphylococcus aureus and a gram-negative bacillus were isolated in subsequent blood cultures. The colony morphology of the gram-negative bacillus on sheep blood agar was grayish, non-hemolytic, circular, smooth, and convex. It was identified as H. huttiense by matrix-associated laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS; MicroFlex LT, Bruker Daltonics GmbH, Leipzig, Germany) with an identification log score of 2.30, but as a member of the Burkholderia cepacia group by the VITEK 2 system (bioMérieux, Marcy l'Etoile, France). The strain produced acid using adonitol, L-arabitol, D-glucose, and D-mannitol as substrates and could utilize D-mannose and D-sorbitol as carbon sources. Moreover, the strain was positive for malonate, citrate, L-lactate, and succinate alkalinization, as well as beta-galactosidase, gamma-glutamyl transferase, L-proline arylamidase, tyrosine arylamidase, and L-malate assimilation, based on the VITEK 2 gram-negative identification card. To confirm the bacterial species, 16S rRNA gene was sequenced with the following primer pairs, according to the CLSI guidelines: forward primer, 4F: 5′-TTG GAG AGT TTG ATC CTG GCT C-3′ and reverse primer, 534R: 5′-TAC CGC GGC TGC TGG CAC-3′ and forward primer 27F: 5′-AGA GTTTGA TCM TGG CTC AG-3′ and reverse primer 801R: 5′-CGGC GTG GAC TTC CAG GGT ATC T-3′ [5]. When the sequence was submitted in the EzTaxon database v2.1 (http://www.ezbiocloud.net), the highest similarity was obtained with H. huttiense subsp. huttiense (100%), followed by H. huttiense subsp. putei (99.86%) and H. aquaticum (99.58%). Phylogenetic analysis showed that this isolate was very similar to H. huttiense subsp. huttiense (Fig. 1). Antimicrobial susceptibility tests using VITEK 2 demonstrated ceftazidime, meropenem, minocycline, and trimethoprim/sulfamethoxazole susceptibility and colistin resistance. H. huttiense was repeatedly isolated for 10 days from 12 aerobic bottles of 15 pairs of blood culture sets. Meropenem and colistin were administered to the patient for 10 days, and the regimen was changed to ceftazidime, minocycline, and trimethoprim/sulfamethoxazole thereafter. Two months later, the patient's condition deteriorated, and H. huttiense was isolated again in the sputum for a week. After approximately one month of conservative treatment, the patient was transferred to a long-term care facility.

Fig. 1. Neighbor-joining phylogenetic tree based on 16S rRNA gene sequences of Herbaspirillum species, including the H. huttiense strain isolated in this clinical case. H. huttiense is compared with eight other similar organisms.

Fig. 1

Because of the phylogenetic and phenotypic resemblance, current biochemical identification systems, including the VITEK 2 system, are unable to identify the Herbaspirillum species and may confuse Herbaspirillum with other organisms such as B. cepacia complex, Ralstonia spp., Cupriavidus pauculus, or Ochrobactrum anthropi [6,7]. Therefore, Herbaspirillum species may be more prevalent pathogens than previously thought. Antimicrobial susceptibility can serve as a means for differentiating Herbaspirillum species from B. cepacia complex because the latter are usually multidrug resistant, whereas the former are not [8]. In our case, the strain was susceptible to all antimicrobial drugs except colistin, based on the CLSI Interpretive Guidelines for other non-Enterobacteriaceae [9]. However, despite adequate treatment, microbiological eradication was not achieved, and septicemia lasted for several days, in contrast to a previous report [6].

The H. huttiense strain isolated from blood and sputum specimens was successfully identified using MALDI-TOF MS. The rapid identification rate and high discriminatory power of MALDI-TOF MS makes it a useful tool for the characterization of microorganisms that are rarely reported as human pathogens and are difficult to identify using routine methods [10].

In conclusion, we report a case of septicemia due to H. huttiense in an immunocompetent patient. Although Herbaspirillum species are rarely reported as pathogens, this possibility should be carefully evaluated. The prognosis of H. huttiense infection needs to be further studied.

Footnotes

Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

References

  • 1.Baldani JI, Pot B, Kirchhof G, Falsen E, Baldani VL, Olivares FL, et al. Emended description of Herbaspirillum; inclusion of [Pseudomonas] rubrisubalbicans, a milk plant pathogen, as Herbaspirillum rubrisubalbicans comb. nov.; and classification of a group of clinical isolates (EF group 1) as Herbaspirillum species 3. Int J Syst Bacteriol. 1996;46:802–810. doi: 10.1099/00207713-46-3-802. [DOI] [PubMed] [Google Scholar]
  • 2.Dobritsa AP, Reddy MC, Samadpour M. Reclassification of Herbaspirillum putei as a later heterotypic synonym of Herbaspirillum huttiense, with the description of H. huttiense subsp. huttiense subsp. nov. and H. huttiense subsp. putei subsp. nov., comb. nov., and description of Herbaspirillum aquaticum sp. nov. Int J Syst Evol Microbiol. 2010;60:1418–1426. doi: 10.1099/ijs.0.009381-0. [DOI] [PubMed] [Google Scholar]
  • 3.Berg G, Eberl L, Hartmann A. The rhizosphere as a reservoir for opportunistic human pathogenic bacteria. Environ Microbiol. 2005;7:1673–1685. doi: 10.1111/j.1462-2920.2005.00891.x. [DOI] [PubMed] [Google Scholar]
  • 4.Regunath H, Kimball J, Smith LP, Salzer W. Severe community-acquired pneumonia with bacteremia caused by Herbaspirillum aquaticum or Herbaspirillum huttiense in an immune-competent adult. J Clin Microbiol. 2015;53:3086–3088. doi: 10.1128/JCM.01324-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.CLSI. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. CLSI MM18-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2008. [Google Scholar]
  • 6.Spilker T, Uluer AZ, Marty FM, Yeh WW, Levison JH, Vandamme P, et al. Recovery of Herbaspirillum species from persons with cystic fibrosis. J Clin Microbiol. 2008;46:2774–2777. doi: 10.1128/JCM.00460-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ziga ED, Druley T, Burnham CA. Herbaspirillum species bacteremia in a pediatric oncology patient. J Clin Microbiol. 2010;48:4320–4321. doi: 10.1128/JCM.01479-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chemaly RF, Dantes R, Shah DP, Shah PK, Pascoe N, Ariza-Heredia E, et al. Cluster and sporadic cases of Herbaspirillum species infections in patients with cancer. Clin Infect Dis. 2015;60:48–54. doi: 10.1093/cid/ciu712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.CLSI. Performance standards for antimicrobial susceptibility testing. CLSI M100-S26. Wayne, PA: Clinical and Laboratory Standards Institute; 2017. [Google Scholar]
  • 10.van Belkum A, Chatellier S, Girard V, Pincus D, Deol P, Dunne WM., Jr Progress in proteomics for clinical microbiology: MALDI-TOF MS for microbial species identification and more. Expert Rev Proteomics. 2015;12:595–605. doi: 10.1586/14789450.2015.1091731. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Laboratory Medicine are provided here courtesy of Korean Society for Laboratory Medicine

RESOURCES